FDA Inspection 969277 — Abbvie Biotechnology Ltd.

Abbvie Biotechnology Ltd. — FEI 3004620772

The FDA completed an inspection of Abbvie Biotechnology Ltd. on March 24, 2016 in Barceloneta, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 24, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)